The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 09, 2025 for Dr. B S Ajaikumar & Others
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The BSA promoter group of HCG (Dr. B.S. Ajaikumar and four family members) has filed an encumbrance disclosure covering their combined ~10.86% holding in the company. The encumbrance is not a financial pledge but a contractual transfer restriction arising from a Promoter Agreement signed on 23 February 2025 with Hector Asia Holdings II Pte. Ltd. (which holds 51.41%) and KIA EBT II Scheme 1. The restriction prevents the Ajaikumar family from selling or pledging their shares except through permitted sale mechanisms, an Eligible Pledge up to 5% of share capital, or with prior consent of the Purchasers. Dr. B.S. Ajaikumar's encumbered position is only 5.7% of his promoter shareholding, well below the 50% disclosure threshold. No money has been borrowed against the shares and the entity in whose favour the encumbrance exists is not a bank or NBFC.
This is a procedural compliance filing linked to the change-of-control transaction where Hector Asia became the majority owner. It signals long-term alignment of the founding family with the new controlling shareholder rather than any financial stress. No immediate effect on share price is expected from this disclosure.